Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 1
2004 2
2005 1
2006 3
2007 2
2008 4
2009 5
2010 8
2011 4
2012 10
2013 4
2014 4
2015 7
2016 5
2017 4
2018 2
2019 5
2020 6
2021 13
2022 21
2023 19
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

124 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean chang yu wang[Author] (43 results)?
Utility of ChatGPT in Clinical Practice.
Liu J, Wang C, Liu S. Liu J, et al. Among authors: wang c. J Med Internet Res. 2023 Jun 28;25:e48568. doi: 10.2196/48568. J Med Internet Res. 2023. PMID: 37379067 Free PMC article.
The NLRP3 inflammasome in fibrosis and aging: The known unknowns.
Liu Y, Xu X, Lei W, Hou Y, Zhang Y, Tang R, Yang Z, Tian Y, Zhu Y, Wang C, Deng C, Zhang S, Yang Y. Liu Y, et al. Among authors: wang c. Ageing Res Rev. 2022 Aug;79:101638. doi: 10.1016/j.arr.2022.101638. Epub 2022 May 5. Ageing Res Rev. 2022. PMID: 35525426 Review.
Targeting HMGB1 for the treatment of sepsis and sepsis-induced organ injury.
Deng C, Zhao L, Yang Z, Shang JJ, Wang CY, Shen MZ, Jiang S, Li T, Di WC, Chen Y, Li H, Cheng YD, Yang Y. Deng C, et al. Acta Pharmacol Sin. 2022 Mar;43(3):520-528. doi: 10.1038/s41401-021-00676-7. Epub 2021 May 26. Acta Pharmacol Sin. 2022. PMID: 34040166 Free PMC article. Review.
Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates.
Brahmer JR, Drake CG, Wollner I, Powderly JD, Picus J, Sharfman WH, Stankevich E, Pons A, Salay TM, McMiller TL, Gilson MM, Wang C, Selby M, Taube JM, Anders R, Chen L, Korman AJ, Pardoll DM, Lowy I, Topalian SL. Brahmer JR, et al. Among authors: wang c. J Clin Oncol. 2010 Jul 1;28(19):3167-75. doi: 10.1200/JCO.2009.26.7609. Epub 2010 Jun 1. J Clin Oncol. 2010. PMID: 20516446 Free PMC article. Corrected and republished. Clinical Trial.
Genome-wide profiling of HPV integration in cervical cancer identifies clustered genomic hot spots and a potential microhomology-mediated integration mechanism.
Hu Z, Zhu D, Wang W, Li W, Jia W, Zeng X, Ding W, Yu L, Wang X, Wang L, Shen H, Zhang C, Liu H, Liu X, Zhao Y, Fang X, Li S, Chen W, Tang T, Fu A, Wang Z, Chen G, Gao Q, Li S, Xi L, Wang C, Liao S, Ma X, Wu P, Li K, Wang S, Zhou J, Wang J, Xu X, Wang H, Ma D. Hu Z, et al. Among authors: wang c. Nat Genet. 2015 Feb;47(2):158-63. doi: 10.1038/ng.3178. Epub 2015 Jan 12. Nat Genet. 2015. PMID: 25581428
Targeting STAT3: A crucial modulator of sepsis.
Lei W, Liu D, Sun M, Lu C, Yang W, Wang C, Cheng Y, Zhang M, Shen M, Yang Z, Chen Y, Deng C, Yang Y. Lei W, et al. Among authors: wang c. J Cell Physiol. 2021 Nov;236(11):7814-7831. doi: 10.1002/jcp.30394. Epub 2021 Apr 22. J Cell Physiol. 2021. PMID: 33885157 Review.
Adjuvant chemotherapy versus adjuvant concurrent chemoradiotherapy after radical surgery for early-stage cervical cancer: a randomized, non-inferiority, multicenter trial.
Weng D, Xiong H, Zhu C, Wan X, Chen Y, Wang X, Zhang Y, Jiang J, Zhang X, Gao Q, Chen G, Xing H, Wang C, Li K, Chen Y, Mao Y, Hu D, Pan Z, Chen Q, Cui B, Song K, Yi C, Peng G, Han X, An R, Fan L, Wang W, Xiong T, Chen Y, Tang Z, Li L, Yang X, Cheng X, Lu W, Wang H, Kong B, Xie X, Ma D. Weng D, et al. Among authors: wang c. Front Med. 2023 Feb;17(1):93-104. doi: 10.1007/s11684-021-0892-z. Epub 2022 Nov 23. Front Med. 2023. PMID: 36422763 Free PMC article. Clinical Trial.
Phase I Study of Single-Agent Anti-Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates.
Brahmer JR, Drake CG, Wollner I, Powderly JD, Picus J, Sharfman WH, Stankevich E, Pons A, Salay TM, McMiller TL, Gilson MM, Wang C, Selby M, Taube JM, Anders R, Chen L, Korman AJ, Pardoll DM, Lowy I, Topalian SL. Brahmer JR, et al. Among authors: wang c. J Clin Oncol. 2023 Feb 1;41(4):715-723. doi: 10.1200/JCO.22.02270. J Clin Oncol. 2023. PMID: 36706735
124 results